DFTX

DFTX is exhibiting Stage 3 distribution after a Blow-Off Top, with broken higher-high/higher-low structure and rallies repeatedly rejected by the 9 EMA and 21 EMA in an overbought context—supporting a medium-term bearish bias and a Sell Now execution at dynamic resistance.

• ↑DT120 ODT Phase 3 Emerge trial met primary endpoints with significant symptom improvement and favorable safety profile.
• ↑Upsized public offering raised ~$805 M; ended Q1 with $373 M cash runway through key readouts.
• ↓Q1 net loss $77 M vs $23 M prior, raising concerns over cash flow sustainability.